{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:12:09Z","timestamp":1778911929237,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA106183"],"award-info":[{"award-number":["T32CA106183"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jss.2022.10.085","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:45:21Z","timestamp":1671597921000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association of Systemic Chemotherapy Approaches With Outcomes in Appendiceal Peritoneal Metastases"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-0328","authenticated-orcid":false,"given":"David N.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Macfie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad O.","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hermina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Mina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Eun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Labow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Golas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Sarpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Magge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2022.10.085_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.6004\/jnccn.2014.0109","article-title":"Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN oncology outcomes database for colorectal cancer","volume":"12","author":"Tejani","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2022.10.085_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","article-title":"Predicting survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendix adenocarcinoma","volume":"61","author":"Aziz","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jss.2022.10.085_bib3","first-page":"1547","article-title":"Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis","volume":"22","author":"Pallas","year":"2017","journal-title":"J BUON"},{"key":"10.1016\/j.jss.2022.10.085_bib4","first-page":"129","article-title":"Principles and innovations in peritoneal surface malignancy treatment","volume":"4","author":"MacArthur","year":"2013","journal-title":"World J Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","article-title":"Outcomes following cytoreduction and HIPEC for pseudomyxoma peritonei: 10-year experience","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jss.2022.10.085_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","article-title":"Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"219","author":"Beal","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2022.10.085_bib7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13193-015-0478-9","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours","volume":"7","author":"Lansom","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0035-1564433","article-title":"Management of appendix cancer","volume":"28","author":"Kelly","year":"2015","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.jss.2022.10.085_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","article-title":"Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Baratti","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib12","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1245\/s10434-013-3469-5","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix","volume":"21","author":"McConnell","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib13","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.32881","article-title":"The chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"126","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2022.10.085_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejso.2015.01.005","article-title":"Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)","volume":"41","author":"Milovanov","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2022.10.085_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jso.21679","article-title":"Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin","volume":"102","author":"Sugarbaker","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib19","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","article-title":"Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Jimenez","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","article-title":"Neoplasms of the appendix: current treatment guidelines","volume":"26","author":"Shankar","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jss.2022.10.085_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","article-title":"Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved","volume":"56","author":"Dayal","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jss.2022.10.085_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.25967","article-title":"Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer","volume":"122","author":"Chen","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib23","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2019.05.008","article-title":"Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin","volume":"45","author":"Munoz-Zuluaga","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.10.085_bib25","first-page":"783","article-title":"Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC","volume":"22","author":"Spiliotis","year":"2017","journal-title":"J BUON"},{"key":"10.1016\/j.jss.2022.10.085_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National cancer data base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2022.10.085_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/SLA.0b013e31819ec7e3","article-title":"Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the mayo clinic experience","volume":"249","author":"Schomas","year":"2009","journal-title":"Ann Surg"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422007193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422007193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:01:40Z","timestamp":1758380500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480422007193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"alternative-id":["S0022480422007193"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2022.10.085","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Systemic Chemotherapy Approaches With Outcomes in Appendiceal Peritoneal Metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2022.10.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}